Skip to main content Back to Top
Advertisement

1/6/2021

Famotidine Tablets

Products Affected - Description

    • Famotidine tablet, Alembic, 20 mg, bottle, 100 count, NDC 62332-0001-31
    • Famotidine tablet, Alembic, 20 mg, bottle, 1000 count, NDC 62332-0001-91
    • Famotidine tablet, Alembic, 40 mg, bottle, 100 count, NDC 62332-0002-31
    • Famotidine tablet, Alembic, 40 mg, bottle, 500 count, NDC 62332-0002-71
    • Famotidine tablet, Alembic, 40 mg, bottle, 1000 count, NDC 62332-0002-91
    • Famotidine tablet, Major, 20 mg, bottle, 100 count, NDC 00536-1298-01
    • Famotidine tablet, Teva, 20 mg, bottle, 100 count, NDC 00172-5728-60
    • Famotidine tablet, Teva, 20 mg, bottle, 500 count, NDC 00172-5728-70
    • Famotidine tablet, Teva, 20 mg, bottle, 1000 count, NDC 00172-5728-80
    • Famotidine tablet, Teva, 40 mg, bottle, 100 count, NDC 00172-5729-60
    • Famotidine tablet, Teva, 40 mg, bottle, 500 count, NDC 00172-5729-70

Reason for the Shortage

    • Alembic has famotidine tablets on allocation due to increased demand.
    • Aurobindo refuses to provide availability information.
    • Major did not provide a reason for the shortage.
    • Mylan discontinued famotidine tablets in all presentations in April 2019.
    • Teva has famotidine tablets on shortage due to increased demand.
    • Bausch Health did not provide a reason for the shortage.
    • Dr. Reddy's discontinued famotidine tablets in all presentations.

Available Products

    • Pepcid tablet, Bausch Health, 20 mg, bottle, 30 count, NDC 00187-4420-30
    • Pepcid tablet, Bausch Health, 20 mg, bottle, 100 count, NDC 00187-4420-10
    • Pepcid tablet, Bausch Health, 40 mg, bottle, 30 count, NDC 00187-4440-30
    • Pepcid tablet, Bausch Health, 40 mg, bottle, 100 count, NDC 00187-4440-10

Estimated Resupply Dates

    • Alembic has famotidine tablets on allocation.
    • Major has famotidine 20 mg tablets on back order and the company estimates a release date of mid-February 2021.
    • Teva has famotidine tablets on intermittent back order and the company estimates the next release in January 2021.

Updated

Updated January 6, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 4, 2019 by Rachael Freeman, PharmD, BCPS. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.